NOTCH1 and cancer: Given the high frequencyof NOTCH1 mutations in early-onset squamous cell carcinoma of the oralcavity and oropharynx, Notch signaling pathway inhibitors that have shown efficacy inother types of cancer could be considered as an additional therapeutic approach intreating young patients with this cancer (Kolegova etal., 2022).